Aaron Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History

Aaron Wealth Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-56,148	Closed	-$439K	–	866
2022 Q1	$439K	Buy	+56,148	New	+$6.77M	0.01%	545
2021 Q4	–	Sell	-7,611	Closed	-$1.08M	–	184
2021 Q3	$1.08M	Buy	7,611 +35	+0.5%	+$5.15K	0.3%	44
2021 Q2	$1.18M	Sell	7,576 -348	-4%	-$56.4K	0.39%	41
2021 Q1	$1.23M	Buy	+7,924	New	+$1.23M	0.45%	40

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aaron Wealth Advisors's ZBH Position: Q2 2022 in Review

Aaron Wealth Advisors sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 56,148 shares — an estimated $439K sold.

Aaron Wealth Advisors first reported a position in ZBH in Q1 2021 and held it in 4 quarters. The position peaked at $1.23M in Q1 2021. 956 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

Aaron Wealth Advisors reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
Aaron Wealth Advisors sold 56,148 Zimmer Biomet shares in Q2 2022, an estimated $439K.
Aaron Wealth Advisors first reported a position in Zimmer Biomet in Q1 2021 and held it in 4 quarters.
Aaron Wealth Advisors's Zimmer Biomet position peaked at $1.23M in Q1 2021.
956 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Aaron Wealth Advisors's 13F filing for Q2 2022, filed 22 Jul 2022.